Citigroup initiated coverage on Pear Therapeutics with a new price target
$PEAR
Computer Software: Prepackaged Software
Technology
Citigroup initiated coverage of Pear Therapeutics with a rating of Buy and set a new price target of $13.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/26/2022 | $5.00 | Neutral | B of A Securities |
1/20/2022 | $11.00 | Outperform | Credit Suisse |
1/3/2022 | $12.00 | Buy | BTIG Research |
12/29/2021 | $13.00 | Buy | Citigroup |
12/22/2021 | $16.00 | Buy | Chardan Capital |
12/16/2021 | Outperform | Cowen & Co. |